List your company

Target ID

Drug discovery and biotech · by META D3

TargetExplore deploys AI to prioritize biologically relevant targets for diseases, evaluating diverse biological parameters and literature strength to enhance efficiency and accuracy of target selection in drug discovery.

Visit website

What it does

TargetExplore deploys AI to prioritize biologically relevant targets for diseases, evaluating diverse biological parameters and literature strength to enhance efficiency and accuracy of target selection in drug discovery.

  • target identification
  • biomarker candidate discovery
  • SAR and de novo molecule generation
  • ADC design
  • PROTAC design
  • antibody engineering
  • indication prioritisation
  • drug reformulation
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
pharma innovators, drug discovery researchers
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

META D3 doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

META D3 hasn't published certifications or security practices for Target ID that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use Target ID at work. Share how your team uses it to help other buyers decide.

Write a review

Alternatives

  • ITO™ Platform

    by 1910

    Cloud-based end-to-end platform integrating massive multimodal data, frontier AI models, and high-throughput lab automation to deliver small and large molecule drug candidates f...

  • AI Agents

    by Enjamb Labs

    Agentic orchestration that coordinates specialized agents across evidence, trial design, statistical programming, and regulatory writing inside one auditable workspace.

  • Integrations

    by Invert

    Pre-built connectivity to every instrument, historian, ELN/LIMS, and enterprise data store that matters in bioprocess.

  • Numerion Labs Drug Discovery Platform

    by Numerion Labs

    AI-driven drug-hunting superplatform that uses a universal chemistry foundation model (COSMOS), a hyper-scalable enumerator (APEX), and expert optimization algorithms (EXPO) to...

  • Quinn

    Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets.

  • Precision medicine

    by Parallel Bio

    Maps of human biology for personalized insights and patient stratification in ways never previously possible.

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Target ID